A Cancer Story Guaranteed To Brighten Your Day

Cancer doesn't care who you are or what your dreams are. It is indiscriminate, striking good people and bad people, young and old.

While we are learning more and more about the broad spectrum of diseases that constitute the term "cancer," we still have a long way to go, and today's patients will get little out of laboratory advances; they need help now.

That help can come in several forms, one being hope and inspiration. So when a story comes along that delivers both of these in spades, it is imperative that we pass it along and make sure it reaches as many people who can use a brighter day as possible.

I occasionally do some hockey writing (samples published on this site include this article and this article) and one of my colleagues at thehockeywriters.com has written an inspirational true story about a remarkable teenager who, at 13 and diagnosed with bone cancer, made a decision none of us would ever want to make.

Despite all odds, four years later the kid is thriving.

Read his remarkable story here: Ty Ulmer: Making the Biggest Save of His Life, written by Shawn Reznik.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap